Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/1995
04/18/1995US5407955 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
04/18/1995US5407951 Sulphonamidocycloalkane compounds, pharmaceutical compositions containing them, and methods of use thereof
04/18/1995US5407941 Platelet activating factor antagonist and antihistamine; useful for treating asthma and allergic disorders
04/18/1995US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these
04/16/1995CA2118092A1 Methods of inhibiting endometriosis
04/16/1995CA2118090A1 Methods of inhibiting uterine fibrosis
04/12/1995EP0647621A1 Aryl and heterocylic cyanoguanidine derivatives
04/12/1995EP0647266A1 D-enzyme compositions and methods of their use
04/12/1995EP0647236A1 Endothelin antagonists ii
04/12/1995EP0647221A1 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs
04/11/1995US5405945 DNA encoding reproductive hormones and expression using a minigene
04/11/1995US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems
04/08/1995CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives
04/08/1995CA2132766A1 4-arylamino-benzopyran and related compounds
04/06/1995WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
04/06/1995WO1995009011A1 Methods of stimulating phagocytosis
04/06/1995WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/06/1995WO1995009006A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
04/06/1995CA2172393A1 Methods of stimulating phagocytosis
04/06/1995CA2167526A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/05/1995EP0646012A1 Wound healing and treatment of fibrotic disorders
04/05/1995CN1101039A 哌嗪衍生物 Piperazine derivatives
04/04/1995US5403851 Substituted tryptamines, phenalkylamines and related compounds
04/04/1995US5403847 Use of α1C specific compounds to treat benign prostatic hyperlasia
04/04/1995US5403842 Benzopyran and benzothiopyran derivatives
03/1995
03/29/1995EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase
03/29/1995EP0644885A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same
03/29/1995CN1100721A Imidazopyridine
03/29/1995CN1100634A Method of preventing emesis and treating sexual dyfunction using tetra hydrobenzÛCDÙ indole-6-carboxamides
03/28/1995US5401851 Preparation of proline derivatives
03/28/1995US5401776 Use of modafinil for the treatment of urinary and fecal incontinence
03/28/1995US5401758 For treating ischemia
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/23/1995WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/23/1995CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
03/22/1995EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
03/22/1995EP0557301B1 5-fluoro-2,4,6-pyrimidinetriamine compounds for preventing hair loss
03/22/1995EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid
03/22/1995CN1100416A Derivative of 2-amino-N-ÛÛÛ4-(aminocarbonyl)pyrimidin-2-ylÙamizoÙalkylÙpyrimidiny-4-carboxamide, preparation and pharmaceutical application of same
03/21/1995US5399696 Excitatory amino acid receptor antagonists; nervous system disorders
03/21/1995US5399587 Biologically active compounds
03/21/1995US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/21/1995US5399359 Controlled release oxybutynin formulations
03/16/1995WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents
03/16/1995WO1995007075A1 Novel aromatic amine derivatives
03/16/1995WO1995003405A3 Enzymatic method for modification of recombinant polypeptides
03/16/1995CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders
03/15/1995EP0642794A1 Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0510028B1 Thioformamide derivatives
03/14/1995US5397776 Vitamin D compounds with anti-progesterone activity
03/09/1995WO1995006634A1 New 9-chloro-prostaglandin derivatives
03/09/1995CA2170613A1 New 9-chloro-prostaglandin derivatives
03/08/1995EP0641791A1 Novel benzothiophene derivative
03/08/1995EP0641565A1 Contraceptive and menstrual cycle controlling drug having oncostatic properties
03/08/1995EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
03/08/1995EP0641329A1 Compounds having angiotensine ii antagonistic activity
03/08/1995EP0641326A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
03/08/1995EP0641302A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
03/08/1995EP0641203A1 Imidazolyl-alkenoic acids
03/08/1995EP0641202A1 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/07/1995US5395825 Medical diagnosis of infertility in females
03/02/1995WO1995006046A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995WO1995005822A1 Inhibition of smooth muscle cell migration by (r)-amlodipine
03/02/1995WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995CA2170279A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/01/1995EP0640606A1 Thienopyrimidine derivatives, their production and use
03/01/1995EP0640599A1 4-Aminopyrimidine derivatives
03/01/1995EP0640596A1 N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists
03/01/1995EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
03/01/1995EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation
03/01/1995EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use
03/01/1995EP0518908B1 Method for polymerization of epoxide compounds
03/01/1995CA2130971A1 Sulfonamide endothelin antagonists
02/1995
02/28/1995US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them
02/28/1995US5393747 Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists
02/27/1995CA2130859A1 Thienopyrimidine derivatives, their production and use
02/23/1995WO1995005188A1 Erection-inducing methods and compositions
02/23/1995WO1995005172A1 Methods for modulating the human sexual response
02/22/1995EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
02/22/1995EP0639377A1 Vitamin D compounds with anti-progesterone activity
02/22/1995CN1098907A Dry mix formulation for bisphosphonic acids
02/21/1995US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses
02/16/1995WO1995004730A1 Benzopyrans and pharmaceutical compositions containing them
02/16/1995WO1995004548A1 Prostatic cancer vaccine
02/16/1995WO1995004541A1 N-terminus modified analogs of lhrh
02/16/1995WO1995004530A1 Endothelin receptor antagonists
02/16/1995CA2168952A1 Prostatic cancer vaccine
02/16/1995CA2167834A1 N-terminus modified analogs of lhrh
02/15/1995EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them
02/15/1995EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
1 ... 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 ... 562